Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex.
about
FKBP12 regulates the localization and processing of amyloid precursor protein in human cell linesProtein phosphatases and Alzheimer's diseaseDownregulation of calcineurin activity in cervical carcinomaThe synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degenerationUncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture.Diabetes and Alzheimer's disease - is there a connection?Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice.Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer's disease.Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signalingThe mineral depletion of foods available to us as a nation (1940-2002)--a review of the 6th Edition of McCance and Widdowson.The role of tau in neurodegenerationCalcium phosphatase calcineurin influences tau metabolism.Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.The role of CREB signaling in Alzheimer's disease and other cognitive disorders.Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathiesA role for calcineurin in Alzheimer's disease.The multiple faces of calcineurin signaling in Caenorhabditis elegans: development, behaviour and aging.A novel calcineurin splice variant that modifies calcineurin activity.Tau and neurodegenerative disorders.Progress in the development of new drugs in Alzheimer's disease.Calcineurin proteolysis in astrocytes: Implications for impaired synaptic functionDifferential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease.Yeast as a model system to study tau biology.Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain.CREB-regulated transcription coactivator 1-dependent transcription in Alzheimer's disease mice.A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brain.Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology.Alterations of cyclin dependent kinase 5 expression and phosphorylation in amyloid precursor protein (APP)-transfected PC12 cells.
P2860
Q24336083-533FDD33-4FE9-48F6-A688-56ED5B8BCD2EQ24632495-1615D41A-A38F-4741-8E8B-DF978AAB05C1Q24795040-47C671D6-97E6-4A1A-9CBF-5D23E8E862A8Q27000356-8A3EA462-EC3C-466D-ACBD-4914E0D8C3B4Q30494084-EF8C8E49-7E26-4FA5-87D9-C3E70B0522E1Q33715371-CF5D35B3-5CC2-4AFE-AEC5-26EC3B869AB5Q34429308-A73193E9-A5E2-4D62-82CD-B720C59C6E94Q34493905-FD18D9F9-0501-40D3-8776-FF109D33E52BQ35688763-5A384DBC-C6A8-4518-9E6E-D90C5A01E380Q36035084-B1AF51C1-6ECB-4E4E-9F22-D632FE438D1AQ36039037-360973AB-D8C1-4292-B8B0-D785BF408B0BQ36972735-ECE217C4-C68B-4B99-948A-07C25E25DE84Q37065235-4541E718-EA3F-4A70-AE9E-892F8CA26A85Q37098010-5133DD38-2491-47AC-AD49-B7B1AF55EB91Q37145919-C272C685-8804-4FD5-8AC7-4B359C1A468EQ37427768-240DD1BA-8033-40CD-9B02-E8025BEA92E3Q37434914-CE1911C3-8E3E-4B72-A155-753FD2E62A60Q37602130-C79F73CB-1FD6-4691-8998-8A598E68E3B2Q37832656-BFF581FE-754A-4234-84E2-C2A225E5FEA5Q37863146-A9CC2FCB-4FB2-4F0F-992C-5B666E4F8C0AQ37869409-F64ED462-B210-4E5B-8690-97125349EF81Q38015347-37C6A0BD-A652-4A24-A844-510D6B4F8FABQ38105458-07C20371-FD00-48DD-8AF6-F7F15DD45432Q38294450-B3E52B59-764B-413C-AABA-390DA489C7EDQ38472413-0E1069C6-1DDD-48E4-A9BD-5E2BBC0D35FFQ39789745-7D7B57E4-251F-408C-8080-EA1C37FE246DQ40741759-4578DE2D-A0BE-453E-932D-AE961BB4DFFBQ42099415-37D1E48A-FE43-4093-948E-121793B83729Q42585953-2239BD48-968F-4509-978F-57C8D8897A09Q42729005-023795EC-A7F6-4092-AA61-DA8D8CF48FDEQ46693372-232DF2DB-BB64-44F1-8CC7-382D78A0D2D4Q48196399-C3733872-29E4-4599-964B-9F0ADEB650C3Q48291880-87F90447-FC47-4709-B16E-875ABEF2502DQ48416038-E2217645-9A62-446D-AA56-27F36D05CAAEQ48832254-57A5C4BE-5CF9-4B95-86E9-BDA7183CDFCAQ54379908-01CA1ECF-E4A8-4ECC-8464-B241DFB3C91A
P2860
Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Selective changes of calcineur ...... mer's disease cerebral cortex.
@ast
Selective changes of calcineur ...... mer's disease cerebral cortex.
@en
type
label
Selective changes of calcineur ...... mer's disease cerebral cortex.
@ast
Selective changes of calcineur ...... mer's disease cerebral cortex.
@en
prefLabel
Selective changes of calcineur ...... mer's disease cerebral cortex.
@ast
Selective changes of calcineur ...... mer's disease cerebral cortex.
@en
P2093
P356
P1476
Selective changes of calcineur ...... mer's disease cerebral cortex.
@en
P2093
P304
P356
10.1006/EXNR.2000.7534
P407
P577
2001-01-01T00:00:00Z